Trial Profile
Clinical Trials Insight: 700056404
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 24 May 2010
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 24 May 2010 New trial record